Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.

Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Abstract Text:

    BACKGROUND: Malignant hyperthermia is a pharmacogenetic disorder affecting humans, dogs, pigs, and horses. In the majority of human cases and all cases in animals, malignant hyperthermia has been associated with missense mutations in the skeletal ryanodine receptor (RyR1). METHODS: The authors used a "knock-in" targeting vector to create mice carrying the RyR1 R163C malignant hyperthermia mutation. RESULTS: Validation of this new mouse model of human malignant hyperthermia susceptibility includes (1) proof of transcription of the R163C allele and expression of ryanodine receptor protein in R163C heterozygous and R163C homozygous animals; (2) fulminant malignant hyperthermia episodes in R163C heterozygous mice after exposure to 1.25-1.75% halothane or an ambient temperature of 42 degrees C characterized by increased rectal temperature, respiratory rate, and inspiratory effort, with significant blood biochemical changes indicating metabolic acidosis, ending in death and hyperacute rigor mortis; (3) intraperitoneal pretreatment with dantrolene provided 100% protection from the halothane-triggered fulminant malignant hyperthermia episode; (4) significantly increased sensitivity (decreased effective concentration causing 50% of the maximal response) of R163C heterozygous and homozygous myotubes to caffeine, 4-chloro-m-cresol, and K-induced depolarization; (5) R163C heterozygous and homozygous myotubes have a significantly increased resting intracellular Ca concentration compared with wild type; (6) R163C heterozygous sarcoplasmic reticulum membranes have a twofold higher affinity (Kd = 35.4 nm) for [H]ryanodine binding compared with wild type (Kd = 80.1 nm) and a diminished inhibitory regulation by Mg. CONCLUSIONS: Heterozygous R163C mice represent a valid model for studying the mechanisms that cause the human malignant hyperthermia syndrome.

    Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Anesthesiology

    VOLUME: 105

    Page Numbers: 1164-75

    Journal Abbreviation: Anesthesiology

    ISSN: 0003-3022

    DAY: 3

    MONTH: Dec

    YEAR: 2006

    Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 1300217

    Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Keywords Mesh Terms:

    KEYWORDS: Ryanodine Receptor Calcium Release Chann

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Information

    Substance Name: Deoxyribonuclease EcoRI

    Registry Number: EC 3.1.21.-

    Grant and Affiliation Information for Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.

    AFFILIATION: Department of Anesthesia, Perioperative and Pain Medicine, Brigham & Women's Hospital, Boston, Massachusetts 02115, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAMS

    GRANT: 1R01AR46513

    ACRONYM: AR

    MEDLINETA: Anesthesiology

    REFSOURCE: Anesthesiology. 2006 Dec;105(6):1077-8

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News